Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547468 | SCV000646819 | uncertain significance | Familial acute necrotizing encephalopathy | 2023-07-07 | criteria provided, single submitter | clinical testing | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 469467). This variant has not been reported in the literature in individuals affected with RANBP2-related conditions. This variant is present in population databases (rs776380363, gnomAD 0.005%). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1667 of the RANBP2 protein (p.Gly1667Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004024085 | SCV003752182 | uncertain significance | not specified | 2022-12-15 | criteria provided, single submitter | clinical testing | The c.4999G>A (p.G1667R) alteration is located in exon 20 (coding exon 20) of the RANBP2 gene. This alteration results from a G to A substitution at nucleotide position 4999, causing the glycine (G) at amino acid position 1667 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Diagnostic Laboratory, |
RCV001530139 | SCV001744845 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001530139 | SCV001967044 | uncertain significance | not provided | no assertion criteria provided | clinical testing |